In March 2025, the company declared new plans for just a immediate-to-consumer offering of its Wegovy weight loss drug. The company proven a whole new pharmacy, termed NovoCare, which might demand clients $499 a month for usage of the drug, lower than fifty percent the cost of the drug by way of other pharmaceutical distribution networks.[fifty thr